Birchview Capital, LP - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$141,600
+0.6%
20,0000.0%0.12%
+14.2%
Q2 2023$140,800
+84211.4%
20,0000.0%0.11%
-19.1%
Q1 2023$167
-27.4%
20,0000.0%0.13%
-19.1%
Q4 2022$230
-99.9%
20,0000.0%0.16%
-8.5%
Q3 2022$252,000
+18.9%
20,0000.0%0.18%
+14.9%
Q2 2022$212,000
-34.8%
20,0000.0%0.15%
-34.2%
Q1 2022$325,000
+17.3%
20,0000.0%0.23%
+30.7%
Q4 2021$277,000
-3.5%
20,0000.0%0.18%
-8.2%
Q3 2021$287,000
-9.2%
20,0000.0%0.20%
+3.2%
Q2 2021$316,000
+55.7%
20,0000.0%0.19%
+56.2%
Q1 2021$203,000
+36.2%
20,0000.0%0.12%
+40.7%
Q4 2020$149,000
+8.0%
20,000
-50.0%
0.09%
+87.0%
Q3 2020$138,000
+45.3%
40,000
+100.0%
0.05%
-19.3%
Q2 2020$95,000
+137.5%
20,0000.0%0.06%
+62.9%
Q1 2020$40,000
-42.0%
20,0000.0%0.04%
-30.0%
Q4 2019$69,000
+21.1%
20,0000.0%0.05%
+31.6%
Q3 2019$57,000
-25.0%
20,0000.0%0.04%
-17.4%
Q2 2019$76,00020,0000.05%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders